|
10.00 |
Welcome and Introduction
|
|
10.10 |
PLENARY LECTURE
The future of
bioinformatics and its impact on drug discovery
Professor Janet Thornton
(University College London)
|
|
11.00 |
Sense and sensitivity
in sequence analysis: Bioinformatics after target discovery
Dr David Parry-Smith (BioFocus) |
|
11.40 |
COFFEE
|
|
12.00 |
Making lead discovery
less complex
Dr Mike Hann (GlaxoSmithKline)
view
powerpoint presentation
|
|
12.40 |
Recent advances in
virtual screening: Scoring of protein-ligand interactions
Dr Alexander Alex
(Pfizer)
|
|
1.10 |
LUNCH
|
|
2.00 |
In silico predictions
of ADME properties: Today’s approaches and future directions
Dr Han van de Waterbeemd
(Pfizer)
|
|
2.40 |
Hit to lead case
studies
Dr Andrew Baxter (AstraZeneca) |
|
3.10 |
TEA
|
|
3.40 |
From de novo
structure-based design to pharmacophore fingerprinting and
combinatorial library design: Experiences with factor Xa
inhibitors
Dr Jonathan Mason
(Pfizer)
|
|
4.20 |
Lead hopping and
focused library design applied to the synthesis of activators of
the nitric oxide
sensor- soluble guanylate cyclase
Dr David Sellwood (The
Wolfson Institute for Biomedical Research)
view
powerpoint presentation
|
|
5.00 |
CLOSE |